Discussing Patient-Reported Hope in Early Phase Clinical Trials With Debra Lundquist, PhD, RN

At the recent American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois, Debra Lundquist, PhD, RN, of Massachusetts General Hospital and colleagues presented their poster that sought to bridge the gap between recent advances in individual therapy which led to improved outcomes and a better understanding of patient-reported hope, quality of life, symptom burden, and coping mechanisms in early phase clinical trial participants. 

Continue reading

Addressing Racial Disparities in Multiple Myeloma Treatment Outcomes With Rahul Banerjee, MD, and Samer Al Hadidi, MD, MS, FACP

Oncology Data Advisor™ · Addressing Racial Disparities in Multiple Myeloma Treatment Outcomes Research has shown that Black American patients with multiple myeloma experience significant disparities in treatment patterns and outcomes compared with White patients. In this interview, Oncology Data Advisor editorial board member Dr. Rahul Banerjee speaks with Dr. Samer Al Hadidi, Assistant Professor at the University of Arkansas Medical School and a leading researcher in the field of m...

Continue reading

From the Patient’s Perspective: Improving Quality of Care for the LGBTQIA+ Community With Reverend Sean Parker Dennison

Oncology Data Advisor™ · From the Patient’s Perspective: Improving Quality of Care for the LGBTQIA+ Community At the recent 47th Annual Oncology Nursing Society (ONS) Congress, Reverend Sean Parker Dennison, alongside three other professionals, held a panel that explored the topic of improving quality of care for LGBTQIA+ individuals with cancer. In this follow-up interview with Oncology Data Advisor, Reverend Sean expands on their thoughts and provides the valuable perspectiv...

Continue reading

Raising Awareness About Medical Aid in Dying With Janet Rowe and Lisa Vigil Schattinger

At the recent Oncology Nursing Society (ONS) Congress in Anaheim, California, Janet Rowe, RN, and Lisa Vigil Schattinger, MSN, RN, gave a presentation about medical aid in dying and the nurse's role in supporting their terminally ill patients' rights to autonomous decision-making. In this interview with Oncology Data Advisor, Ms. Rowe and Ms. Vigil Schattinger discuss their own experiences with medical aid in dying, explain their work to spread awareness and provide education to the community, and share additional advice for nurses on how to engage patients and families in meaningful conversations about this important issue.

Continue reading

Improving Quality of Care for the LGBTQIA+ Cancer Community With Don S. Dizon, MD

In this interview with Oncology Data Advisor, Dr. Don S. Dizon continues the conversation he had at the recent 47th Annual Oncology Nursing Society (ONS) Congress, where he and three other professionals held a panel to spearhead the topic of improving quality of care for LGBTQIA+ individuals with cancer.

Continue reading

Oncology Nursing Month With Maria Badillo and Diane Barber: How to Build a Diverse Nursing Work Force

In honor of Oncology Nursing Month in May, Oncology Data Advisor is celebrating the stories of these essential members of the cancer care team. For this interview, editorial board member Maria Badillo, MSN, RN, OCN®, CCRP, speaks with Diane Barber, PhD, ANP-BC, AOCNP®, FAAN, Manager of Advanced Practice Providers at MD Anderson Cancer Center. Dr. Barber explains the importance of building a diverse nursing work force and shares ways to spread awareness about the opportunities that a career in nursing can offer.

Continue reading

Oncology Nursing Month With Maria Badillo and Doyle Bosque: The Ever-Changing Opportunities of Research Nursing

Oncology Data Advisor™ · The Ever-Changing Opportunities of Research Nursing In honor of Oncology Nursing Month in May, Oncology Data Advisor is celebrating the stories of these essential members of the cancer care team. For this interview, editorial board member Maria Badillo, MSN, RN, OCN®, CCRP, speaks with Doyle Bosque, RN, Director of Nursing Research Programs at MD Anderson Cancer Center. Mr. Bosque explains the role that he plays in the oversight of clinical trials and shares...

Continue reading

Oncology Nursing Month With Maria Badillo and Sherry Adkins: Nursing Considerations for CAR T-Cell Therapy

Oncology Data Advisor™ · Nursing Considerations for CAR T-Cell Therapy With Maria Badillo and Sherry Adkins In honor of Oncology Nursing Month in May, Oncology Data Advisor is celebrating the stories of these essential members of the cancer care team. For this interview, editorial board member Maria Badillo, MSN, RN, OCN®, CCRP, speaks with Sherry Adkins, MSN, ANP-C, Advanced Practice Provider Supervisor at MD Anderson Cancer Center, about her groundbreaking research in the developm...

Continue reading

Exploring the Impact of Cemiplimab and Pembrolizumab in Cutaneous Squamous Cell Carcinoma With Shaheer Khan, DO

Oncology Data Advisor™ · Exploring the Impact of Cemiplimab and Pembrolizumab in Cutaneous Squamous Cell Carcinoma In honor of Melanoma Awareness Month, Oncology Data Advisor spoke with Dr. Shaheer Khan, an Assistant Professor of Medicine at Columbia University Irving Medical Center. Dr. Khan shares the promising results of two recent trials of cemiplimab and pembrolizumab for cutaneous squamous cell carcinoma, explains future directions in the treatment of patients who are ineligib...

Continue reading

Emerging Checkpoint Inhibitor–Based Strategies for Advanced Endometrial Cancer With Ritu Salani, MD, MBA, and Floor J. Backes, MD

Oncology Data Advisor™ · Emerging Checkpoint Inhibitor–Based Strategies for Advanced Endometrial Cancer Cancer of the uterine corpus, also called endometrial cancer (EC), is the most common cancer of the female genital tract, with an estimated 65,950 new cases diagnosed and 12,550 deaths annually in the United States (ACS, 2022). The mortality rate has increased approximately 1% each year from 2015 to 2019, an increase which may be related to a higher rate of advanced-stage ca...

Continue reading

Taking a Nuanced Approach to Testicular Cancer Management With Sam Kaffenberger, MD

Oncology Data Advisor™ · Taking a Nuanced Approach to Testicular Cancer Management With Sam Kaffenberger, MD For this interview in honor of Testicular Cancer Awareness Month, Dr. Sam Kaffenberger, an Assistant Professor of Urology at the University of Michigan Health System, explains the importance of taking a nuanced approach to the management of individual patients with testicular cancer, with the goal of minimizing toxicity and achieving the best possible outcomes for treatment a...

Continue reading

Prioritizing Life After Testicular Cancer With Katie Murray, DO

Oncology Data Advisor™ · Prioritizing Life After Testicular Cancer With Katie Murray, DO For patients with testicular cancer, planning is necessary to ensure that patients feel prepared regarding the implications of their disease in the years after they finish treatment. In this interview in honor of Testicular Cancer Awareness Month, Dr. Katie Murray, Assistant Professor at the University of Missouri Department of Surgery-Urology, shares advice for members of the cancer care team o...

Continue reading

Can Digital Health Tools Improve Quality of Life in Multiple Myeloma? Insights from Neha Korde, MD, and Rahul Banerjee, MD

Oncology Data Advisor™ · Can Digital Health Tools Improve Quality of Life in Multiple Myeloma? In this interview in honor of Multiple Myeloma Awareness Month, Dr. Rahul Banerjee, a Clinical Fellow in Medicine at the University of California, San Francisco, and member of the Oncology Data Advisor Editorial Board, speaks with Dr. Neha Korde of Memorial Sloan Kettering Cancer Center about the potential of digital health tools to improve quality of life for patients with multiple myelom...

Continue reading

New Insights Into Preventing and Managing Chemotherapy-Induced Neutropenia With Gary Lyman, MD, MPH, and Maura Abbott, PhD, AOCNP®, CPNP

Oncology Data Advisor™ · New Insights Into Preventing and Managing Chemotherapy-Induced Neutropenia Chemotherapy-induced neutropenia (CIN) is a potentially life-threatening toxicity of chemotherapy that has been recognized as a major risk factor for the development of infections in patients with cancer (NCCN, 2021). The severity and duration of neutropenia place patients at higher risk of developing febrile neutropenia (FN) and experiencing dose reductions or delays that may comprom...

Continue reading

Exploring Recent Advances in Testicular Cancer Surgery and Access to Care With Andrew Winer, MD, FACS

Oncology Data Advisor™ · Exploring Recent Advances in Testicular Cancer Surgery and Access to Care This interview in honor of Testicular Cancer Awareness Month features Dr. Andrew Winer, Chief of Urology at Kings County Hospital in New York. Dr. Winer discusses the ongoing research regarding new approaches for testicular cancer surgery, strategies to address disparities in health care access for underserved populations, and the importance of taking a multidisciplinary approach to ac...

Continue reading

Personalizing the Approach to Testicular Cancer Management With Aditya Bagrodia, MD, FACS

Oncology Data Advisor™ · Personalizing the Approach to Testicular Cancer Management With Aditya Bagrodia, MD, FACS This interview in honor of Testicular Cancer Awareness Month features Dr. Aditya Bagrodia, an Associate Professor of Urology at the University of California, San Diego. Dr. Bagrodia explains the factors that should be considered when selecting treatment options—including surgery, chemotherapy, radiation, or surveillance—for patients with testicular cancer, the future of...

Continue reading

Considering Venous Thromboembolism Risk Factors and Prophylaxis in Multiple Myeloma With Rajshekhar Chakraborty, MD, and Rahul Banerjee, MD

Oncology Data Advisor™ · Considering VTE Risk Factors and Prophylaxis in Myeloma: Rajshekhar Chakraborty and Rahul Banerjee In this interview in honor of Multiple Myeloma Awareness Month, Dr. Rahul Banerjee, a Clinical Fellow in Medicine at the University of California, San Francisco, and member of the Oncology Data Advisor Editorial Board, speaks with Dr. Rajshekhar Chakraborty of Columbia University Irving Medical Center about risk factors for the development of venous thromboembo...

Continue reading

Harnessing Immunotherapy-Based Strategies for Advanced Non–Small Cell Lung Cancer With Ticiana Leal, MD, and Beth Sandy, MSN, CRNP

Oncology Data Advisor™ · Harnessing Immunotherapy-Based Strategies for Advanced Non–Small Cell Lung Cancer An estimated 236,740 new cases of lung cancer are reported in the United States annually, and 130,180 people die of the disease. Approximately 84% of cases are classified as non–small cell lung cancer (NSCLC) (ACS, 2022). Though new screening procedures have identified more lung cancers at an earlier stage, most patients are still diagnosed at a locally advanced or metast...

Continue reading

Optimizing Management of Metastatic Squamous Non–Small Cell Lung Cancer With Mark Kris, MD, and Victoria Sherry, DNP, CRNP, AOCNP®

Oncology Data Advisor™ · Optimizing Management of Metastatic Squamous Non-Small Cell Lung Cancer Squamous cell lung carcinoma is a distinct histologic subtype of non–small cell lung cancer (NSCLC) that accounts for approximately 25% to 30% of all NSCLC cases and is associated with approximately 30% shorter survival compared with other subtypes of the disease. Because alterations and mutations for which targeted therapies are approved are uncommon in squamous cell NSCLC, treatment re...

Continue reading

Can Diet and Nutrition Impact Multiple Myeloma Outcomes? Food for Thought From Urvi Shah, MD, and Rahul Banerjee, MD

Oncology Data Advisor™ · Can Diet and Nutrition Impact Multiple Myeloma Outcomes? Urvi Shah and Rahul Banerjee In honor of Multiple Myeloma Awareness Month, Dr. Rahul Banerjee, a Clinical Fellow in Medicine at the University of California, San Francisco, and member of the Oncology Data Advisor editorial board, speaks with Dr. Urvi Shah about the importance of ensuring proper diet and nutrition, as well as the impact of the microbiome, for patients with multiple myeloma. Rahul Banerj...

Continue reading

Copyright © 2022 Oncology Data Advisor. All rights reserved.